Primary Analysis of Juliet: A Global, Pivotal, Phase 2 Trial of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J Schuster , Koen Van Besien + Show 27 more

https://doi.org/10.1182/blood.v130.suppl_1.577.577

Copy DOI

Export

Save

Share

Cite

Journal: Blood	Publication Date: Jun 25, 2021
Citations: 6

Affiliation: University of Pennsylvania, UPMC Hillman Cancer Center, NewYork–Presbyterian Hospital, New York Hospital Queens, Presbyterian Hospital, University of Sydney, Novartis (Switzerland), Tokyo National Hospital, Tris Pharma (United States), Oslo University Hospital, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Academic Medical Center, Hospices Civils de Lyon, University of Kansas Medical Center, Hokkaido University, Hôpital Maisonneuve-Rosemont, Université de Montréal, Emory University, University of Minnesota, University of Milan, The Ohio State University, James Cancer Hospital, Peter MacCallum Cancer Centre, University Hospital Cologne, University of Würzburg, University of Chicago, Medical University of Vienna, Juravinski Hospital, McMaster University, University of Michigan–Ann Arbor, Michigan Center for Translational Pathology, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University

#Research Funding #Advisory Committees #Novartis Pharmaceuticals Corporation #Entity's Board #Board Of Directors #Diffuse Large B-cell Lymphoma #Chimeric Antigen Receptor #Travel Grants #Kyowa Hakko Kirin #Equity Ownership

Abstract
Full-Text
Similar Papers

Abstract

Primary Analysis of Juliet: A Global, Pivotal, Phase 2 Trial of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Full Text

Published Version

Check institute access

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.